The Role of Inflammasome-Dependent and Inflammasome-Independent NLRP3 in the Kidney
Cytoplasmic nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3) forms an inflammasome with apoptosis-associated speck-like protein containing a CARD (ASC) and pro-caspase-1, which is followed by the cleavage of pro-caspase-1 to active caspase-1 and ultimately the activation of...
| Published in: | Cells |
|---|---|
| Main Authors: | Yang Gyun Kim, Su-Mi Kim, Ki-Pyo Kim, Sang-Ho Lee, Ju-Young Moon |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2019-11-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/2073-4409/8/11/1389 |
Similar Items
Chalcone: A potential scaffold for NLRP3 inflammasome inhibitors
by: Pritam Thapa, et al.
Published: (2023-04-01)
by: Pritam Thapa, et al.
Published: (2023-04-01)
NLRP3, NLRP6, and NLRP12 are inflammasomes with distinct expression patterns
by: Bo Wei, et al.
Published: (2024-07-01)
by: Bo Wei, et al.
Published: (2024-07-01)
Fantastic voyage: The journey of NLRP3 inflammasome activation
by: Xiangyong Que, et al.
Published: (2024-03-01)
by: Xiangyong Que, et al.
Published: (2024-03-01)
Role of NLRP3 Inflammasomes in Disorders of Children’s Digestive Systems: A Narrative Review
by: Safaa ELMeneza
Published: (2025-10-01)
by: Safaa ELMeneza
Published: (2025-10-01)
Understanding the Role of NLRP3 Inflammasome in Acute Pancreatitis
by: Konstantinos Papantoniou, et al.
Published: (2024-11-01)
by: Konstantinos Papantoniou, et al.
Published: (2024-11-01)
Progress on the role of NLRP3 inflammasome in hyperuricemic nephropathy
by: DAI Zhixin, WANG Yumin
Published: (2023-02-01)
by: DAI Zhixin, WANG Yumin
Published: (2023-02-01)
Pulmonary fibrosis through the prism of NLRP3 inflammasome: mechanistic pathways and prospective therapeutic innovations
by: Mengxue Wang, et al.
Published: (2025-05-01)
by: Mengxue Wang, et al.
Published: (2025-05-01)
Mechanisms of NLRP3 inflammasome-mediated hepatic stellate cell activation: Therapeutic potential for liver fibrosis
by: Harsh Vardhan Charan, et al.
Published: (2023-03-01)
by: Harsh Vardhan Charan, et al.
Published: (2023-03-01)
NLRP3 Inflammasome in Metabolic-Associated Kidney Diseases: An Update
by: Wei Xiong, et al.
Published: (2021-07-01)
by: Wei Xiong, et al.
Published: (2021-07-01)
The Role of Melatonin on NLRP3 Inflammasome Activation in Diseases
by: Burak Ibrahim Arioz, et al.
Published: (2021-06-01)
by: Burak Ibrahim Arioz, et al.
Published: (2021-06-01)
The Role of NLRP3 Inflammasome Signaling on Arrhythmias in Diabetes
by: Zhang L, et al.
Published: (2022-12-01)
by: Zhang L, et al.
Published: (2022-12-01)
The Novel Role of the NLRP3 Inflammasome in Mycotoxin-Induced Toxicological Mechanisms
by: Chengshui Liao, et al.
Published: (2024-06-01)
by: Chengshui Liao, et al.
Published: (2024-06-01)
NLRP3 Triggers Attenuate Lipocalin-2 Expression Independent with Inflammasome Activation
by: Huijeong Ahn, et al.
Published: (2021-07-01)
by: Huijeong Ahn, et al.
Published: (2021-07-01)
NLRP3 Inflammasome’s Activation in Acute and Chronic Brain Diseases—An Update on Pathogenetic Mechanisms and Therapeutic Perspectives with Respect to Other Inflammasomes
by: Anna Chiarini, et al.
Published: (2023-03-01)
by: Anna Chiarini, et al.
Published: (2023-03-01)
New advances in the activation mechanisms of NLRP3 inflammasome and its inhibitors
by: ZHOU Yong-ting, YE Cai-ying, ZHU Lei
Published: (2020-08-01)
by: ZHOU Yong-ting, YE Cai-ying, ZHU Lei
Published: (2020-08-01)
Expression of NLRP3 inflammasome in leprosy indicates immune evasion of Mycobacterium leprae
by: Ana Luisa Gomes Mendes, et al.
Published: (2020-02-01)
by: Ana Luisa Gomes Mendes, et al.
Published: (2020-02-01)
NLRP3 Inflammasome-Mediated Osteoarthritis: The Role of Epigenetics
by: Yuzhou Liu, et al.
Published: (2025-01-01)
by: Yuzhou Liu, et al.
Published: (2025-01-01)
A detailed molecular network map and model of the NLRP3 inflammasome
by: Marcus Krantz, et al.
Published: (2023-11-01)
by: Marcus Krantz, et al.
Published: (2023-11-01)
The important role of NLRP6 inflammasome in Pasteurella multocida infection
by: Xingping Wu, et al.
Published: (2022-10-01)
by: Xingping Wu, et al.
Published: (2022-10-01)
Novel role for epalrestat: protecting against NLRP3 inflammasome-driven NASH by targeting aldose reductase
by: Wei Shi, et al.
Published: (2023-10-01)
by: Wei Shi, et al.
Published: (2023-10-01)
Research advances in the regulatory mechanisms of NLRP3 inflammasome activation
by: Liu Feng, et al.
Published: (2024-06-01)
by: Liu Feng, et al.
Published: (2024-06-01)
NLRP3 inflammasome in cardiovascular diseases: an update
by: Binhai Mo, et al.
Published: (2025-02-01)
by: Binhai Mo, et al.
Published: (2025-02-01)
The Role of NLRP3 Inflammasomes in Trained Immunity
by: Gilyoung Lee, et al.
Published: (2023-09-01)
by: Gilyoung Lee, et al.
Published: (2023-09-01)
A novel dual NLRP1 and NLRP3 inflammasome inhibitor for the treatment of inflammatory diseases
by: Callum AH Docherty, et al.
Published: (2023-01-01)
by: Callum AH Docherty, et al.
Published: (2023-01-01)
Molecular Mechanisms of Inflammasome in Ischemic Stroke Pathogenesis
by: Maria Grazia Puleo, et al.
Published: (2022-09-01)
by: Maria Grazia Puleo, et al.
Published: (2022-09-01)
Promise of the NLRP3 Inflammasome Inhibitors in In Vivo Disease Models
by: Biswadeep Das, et al.
Published: (2021-08-01)
by: Biswadeep Das, et al.
Published: (2021-08-01)
NLRP11 is required for canonical NLRP3 and non-canonical inflammasome activation during human macrophage infection with mycobacteria
by: Mateusz Szczerba, et al.
Published: (2025-05-01)
by: Mateusz Szczerba, et al.
Published: (2025-05-01)
New insight into the role of the pathway NLRP1 and NLRP3 inflammasomes and IL-33 in ultraviolet-induced cutaneous carcinogenesis
by: Aleksandra Lesiak, et al.
Published: (2025-01-01)
by: Aleksandra Lesiak, et al.
Published: (2025-01-01)
Targeting the inflammasome in Parkinson’s disease
by: Qi Su, et al.
Published: (2022-10-01)
by: Qi Su, et al.
Published: (2022-10-01)
Inhibition of the NLRP3 Inflammasome Activation by Manoalide Ameliorates Experimental Autoimmune Encephalomyelitis Pathogenesis
by: Cong Li, et al.
Published: (2022-02-01)
by: Cong Li, et al.
Published: (2022-02-01)
Inhibition of the NLRP3 inflammasome improves lifespan in animal murine model of Hutchinson–Gilford Progeria
by: Alvaro González‐Dominguez, et al.
Published: (2021-08-01)
by: Alvaro González‐Dominguez, et al.
Published: (2021-08-01)
Microglial NLRP3 inflammasome-mediated neuroinflammation and therapeutic strategies in depression
by: Qiuqin Han, et al.
Published: (2024-01-01)
by: Qiuqin Han, et al.
Published: (2024-01-01)
The Expression and Significance of NLRP3 Inflammasome in Patients with Primary Glomerular Diseases
by: Jing Xiong, et al.
Published: (2015-06-01)
by: Jing Xiong, et al.
Published: (2015-06-01)
NLRP3 inflammasome promotes diabetes-induced endothelial inflammation and atherosclerosis
by: Wan Z, et al.
Published: (2019-09-01)
by: Wan Z, et al.
Published: (2019-09-01)
Progress of NLRP3 inflammasome in the pathogenesis of heart disease
by: GAO Yuan, ZHENG Gang, QI Jing, ZHANG Feng
Published: (2023-07-01)
by: GAO Yuan, ZHENG Gang, QI Jing, ZHANG Feng
Published: (2023-07-01)
Sterile inflammation and the NLRP3 inflammasome in cardiometabolic disease
by: Sungji Cho, et al.
Published: (2023-10-01)
by: Sungji Cho, et al.
Published: (2023-10-01)
The NLRP3 Inflammasome: Metabolic Regulation and Contribution to Inflammaging
by: Allison K. Meyers, et al.
Published: (2020-07-01)
by: Allison K. Meyers, et al.
Published: (2020-07-01)
Mitochondria and the NLRP3 Inflammasome in Alcoholic and Nonalcoholic Steatohepatitis
by: Sandra Torres, et al.
Published: (2022-04-01)
by: Sandra Torres, et al.
Published: (2022-04-01)
The NLRP3 inflammasome: contributions to inflammation-related diseases
by: Ying Chen, et al.
Published: (2023-06-01)
by: Ying Chen, et al.
Published: (2023-06-01)
Review on role of NLRP3 inflammasome in pathogenesis of silicosis
by: Zhenzhen FAN, et al.
Published: (2022-08-01)
by: Zhenzhen FAN, et al.
Published: (2022-08-01)
Similar Items
-
Chalcone: A potential scaffold for NLRP3 inflammasome inhibitors
by: Pritam Thapa, et al.
Published: (2023-04-01) -
NLRP3, NLRP6, and NLRP12 are inflammasomes with distinct expression patterns
by: Bo Wei, et al.
Published: (2024-07-01) -
Fantastic voyage: The journey of NLRP3 inflammasome activation
by: Xiangyong Que, et al.
Published: (2024-03-01) -
Role of NLRP3 Inflammasomes in Disorders of Children’s Digestive Systems: A Narrative Review
by: Safaa ELMeneza
Published: (2025-10-01) -
Understanding the Role of NLRP3 Inflammasome in Acute Pancreatitis
by: Konstantinos Papantoniou, et al.
Published: (2024-11-01)
